Metropolis Healthcare
Metropolis Healthcare Limited, commonly referred to as Metropolis, is a leading diagnostic service provider headquartered in India. Established in 1980, the company has grown to become a prominent player in the healthcare industry, with a strong presence across major operational regions including Mumbai, Delhi, and Bengaluru. Specialising in pathology and diagnostic services, Metropolis offers a comprehensive range of tests, including advanced molecular diagnostics and preventive health check-ups. Their commitment to quality and innovation sets them apart, as they utilise state-of-the-art technology and adhere to stringent quality standards. With over four decades of experience, Metropolis has achieved significant milestones, including numerous accreditations and a vast network of laboratories and collection centres. This positions them as a trusted name in the healthcare sector, dedicated to enhancing patient care through accurate and timely diagnostics.
DitchCarbon Score
How does Metropolis Healthcare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Metropolis Healthcare's score of 27 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Metropolis Healthcare's reported carbon emissions
In 2024, Metropolis Healthcare reported total carbon emissions of approximately 44,218,000 kg CO2e across all scopes. This includes 317,680 kg CO2e from Scope 1, which covers direct emissions from owned or controlled sources, and 6,825,350 kg CO2e from Scope 2, which accounts for indirect emissions from the generation of purchased electricity. Notably, Scope 3 emissions, which encompass all other indirect emissions, were significantly higher at about 44,180,000 kg CO2e. In comparison, the 2023 emissions data showed a total of approximately 44,000 kg CO2e in Scope 3, with Scope 1 and Scope 2 emissions remaining consistent at 317,680 kg CO2e and 6,825,350 kg CO2e, respectively. The 2022 figures indicated a total of about 218,000 kg CO2e in Scope 3 emissions, alongside 220,950 kg CO2e from Scope 1 and 9,815,380 kg CO2e from Scope 2. Despite the substantial emissions, Metropolis Healthcare has not disclosed specific reduction targets or initiatives as part of their climate commitments. The absence of documented reduction targets suggests a need for further clarity on their long-term sustainability strategies. Overall, the company’s emissions profile highlights the importance of addressing both direct and indirect emissions to enhance their climate impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 220,950 | 000,000 | 000,000 |
| Scope 2 | 9,815,380 | 0,000,000 | 0,000,000 |
| Scope 3 | 218,000 | 00,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Metropolis Healthcare is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
